Warner Bros. Discovery, Inc.
Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof

Last updated:

Abstract:

A novel five-membered heteroaromatic imidazole compound and use thereof is disclosed herein. Specifically, disclosed is a compound as shown in formula (III) or a pharmaceutically acceptable salt thereof. Also disclosed is a method for treating a disease related to GLP-1 receptor such as type II diabetes. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

13 Jan 2022

Issue date:

5 May 2022